Fast Facts: Biosimilars in Hematology and Oncology

Biologics and biosimilars - getting decisions right
1. Auflage 2020
ISBN: 978-1-912776-21-4
Verlag: Health Press in S. Karger AG

Buch, Englisch, 128 Seiten, Print metadata, Format (B × H): 148 mm x 210 mm, Gewicht: 220 g

Reihe: FF fast facts

Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.

Autoren/Hrsg.

Cornes, Paul

McBride, Ali